Liu, X., Wang, H., & Zhang, L
However, a placebo-controlled trial in 769 patients with MCI found that the same dosage of vitamin E did not affect the probability of progression from MCI to AD over a three-year period (108)
The research article noted the following findings: 44% lower all-cause mortality 31% lower risk of pulmonary embolism 17% lower risk of venous thromboembolism 21% lower emergency department visits Earlier studies have shown similar results in people with diabetes and chronic kidney disease (CKD)
Marginal deficiency Although frank vitamin E deficiency is rare, marginal intake of vitamin E may be relatively common
Topical application Topical peptide delivery works well for local skin effects
The synergy between CoQ10 and L-carnitine is where this specific combination becomes particularly compelling for managing complex chronic illnesses